Guillermo Garcia-Manero, MD

Videos

Luspatercept vs Epoetin Alfa for Anemia Therapy Among Patients With ESA-Naive, Transfusion-Dependent Lower-Risk MDS

10/10/2023

More patients achieved transfusion-independence and an increase in hemoglobin levels with luspatercept versus epoetin alfa, according to data presented at the SOHO 2023 annual meeting by Guillermo Garcia-Manero, MD.

More patients achieved...

10/10/2023

Oncology

Magrolimab in Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes: 5F9005 Phase 1b Study Results

Introduction:

Deepa Jeyakumar ;

Eunice S. Wang ;

Mark P. Chao ;

Ian W. Flinn ;

Indu Lal ;

Joshua F. Zeidner ;

David A. Sallman ;

Daniel A. Pollyea , MD, MS;

Guillermo Garcia-Manero , MD;

Naval G. Daver ;

Carol O'Hear ;

Paresh Vyas ;

Joseph G. Jurcic ;

Suman N. Kambhampati ;

Lin Gu ;

Monzr M. Al Malki ;

Anderson Tan ;

Adam Asch ;

Tiffany N. Tanaka ;

Terrence J. Bradley ;

11/04/2022

Conference Coverage

Analyzing Management and Treatment Options for Patients With High-Risk MDS

10/08/2024

Guillermo Garcia-Manero , MD;

At the 2024 SOHO meeting, Guillermo Garcia-Manero, MD, shared expert insight into treatment options for patients with high-risk myelodysplastic syndrome.

At the 2024 SOHO meeting,...

10/08/2024

Oncology

Conference Coverage

Examining Current and Upcoming Treatment Options for Patients With Low-Risk MDS

10/04/2024

Guillermo Garcia-Manero , MD;

At the 2024 SOHO meeting, Guillermo Garcia-Manero, MD, shared expert insight into treatment options that are available and upcoming for patients with low-risk myelodysplastic syndrome.

At the 2024 SOHO meeting,...

10/04/2024

Oncology